Repurposed drug yields unprecedented response rates in metastatic...
A targeted therapy resurrected by the Moon Shots Program™ at MD Anderson has produced unprecedented response rates among patients with...
MD Anderson named site of NIH immunotherapy research center
A major national effort to expand the reach of cancer immunotherapy in order to benefit more patients will draw upon the expertise...
'I’ve seen suffering and dying from an avoidable disease'
In Texas, the number is even lower. Only 33% of Texas teens were up to date. That’s a lot of room for improvement.
Having spent the...
MD Anderson pancreatic cancer researcher to lead Dream Team
Deeply entrenched and mature by the time it’s found, pancreatic cancer is one of the hardest types of the disease to defeat. A Dream...
5 years in, Moon Shots Program is primed for continued...
It's been five years since MD Anderson launched its Moon Shots Program™, a collaborative effort to more quickly turn scientific...
Hydrocodone prescriptions decreasing, study shows
The effectiveness of opioids in treating cancer pain has been well established over the years. But today’s opioid epidemic that began...